Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Mitote77 on Feb 03, 2022 10:40am

Buy

You would this at this juncture some investment firm would hit the buy button considering the potential. Or are they just going to wait until this goes over $2? 

anyone?

Comment by Sunvalley on Feb 03, 2022 11:10am
After many years of investing in small cap high potential entities , I can tell you that it seems that the "Boyz" and the so called "Market Makers" along with the shortsellers and assorted wise guys , diddle these stocks as long as possible. That is , scalping a fraction of a cent either way till the cows come home. They will keep doing that even in the face of exciting news ...more  
Comment by pullsea on Feb 03, 2022 11:45am
Totally agree with you on that. Thank you for articulating your style. The SP is acting very nicely though... a bit slow BUT longer the base or FLAG, the bigger the runaway up
Comment by johnsr1 on Feb 04, 2022 8:18am
I thought we were all going to meet in Vegas? Btw, whatever happened to Bunge, wasn't he organizing this party? 8 years in this stock and I think Vegas happens in 2022. Maybe we didn't buy too soon LOL. Jeez, do I ever miss the highlighter, NOT!
Comment by johnsr1 on Feb 04, 2022 8:22am
only the real longs will remember that post
Comment by Sunvalley on Feb 04, 2022 8:48am
Good morning john. You are right. I ment to type L.V.  I,ve been to L.A. and that is a good place to avoid in my Canuck opinion (as is Ottawa LOL) Have a good day.
Comment by Sunvalley on Feb 04, 2022 8:58am
Regarding Bunge , the thought police picked him up a year or two ago for making too many disparaging comments on this board. .He has not been heard from since . Guantanamo Bay should be releasing him any day now LOL.I guess ol Bunge should have toned down on the rhetoric as it was becoming too much even for a hard skinned person like myself.
Comment by robertshaw on Feb 04, 2022 9:34am
Yes, a long nightmare and painful memories for the real long shareholders about the miserable sufference regarding "buy too soon" and the most dedicated basher Blowjobjoe's 24x7 bashing posts,... The good news we are almost at the very end of the black tunnel..
Comment by Infinity on Feb 04, 2022 9:43am
Robertshaw Agree with you. There is a light at the end of the Tunnel. It is looking Brighter by the Day. I expect, we will double in value when BTD is announced. Hopefully very soon. I think by end of 2022 we will no longer be a penny stock. That is when the Institutional investors will be getting into the action if their Prospectus is Biotech stocks..
Comment by Legit62 on Feb 04, 2022 9:54am
That would be great to get some intitutional investors on board, does anyone know if it a $1 price before they can jump in? this would be interesting to know because when we hit a $1 this would really rocket. 
Comment by CAinPlap on Feb 04, 2022 9:55am
I did not think Bunge was a basher and definitely was not the origin of the "bought too soon" That was Bencro(?) or whatever his last handle was. Rest in pieces.  ;) 
Comment by robertshaw on Feb 04, 2022 10:04am
no, Bunge is not a basher, he himself has 200K average  @0.34, the guy who mocked us "bought too soon " is another guy...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250